Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
MLTX holding history
MoonLake Immunotherapeutics in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −86,487−100.0% | Sold out | Holders |
| Q1 2024 | 86,487 | $4.34M | <0.1% | −72,832−45.7% | Reduced | Holders |
| Q4 2023 | 159,319 | $9.62M | <0.1% | −16,718−9.5% | Reduced | Holders |
| Q3 2023 | 176,037 | $10.0M | <0.1% | −18,666−9.6% | Reduced | Holders |
| Q2 2023 | 194,703 | $9.93M | <0.1% | +194,703 | New | Holders |